# Carboplatin, Bevacizumab and Pemetrexed in Advanced Non Small Cell Lung Cancer

> **NCT00614822** · PHASE2 · COMPLETED · sponsor: **Christiana Care Health Services** · enrollment: 50 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** Carboplatin, Pemetrexed and Bevacizumab

## Key facts

- **NCT ID:** NCT00614822
- **Lead sponsor:** Christiana Care Health Services
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2016-08-22
- **Final completion:** 2016-08-22
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00614822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00614822, "Carboplatin, Bevacizumab and Pemetrexed in Advanced Non Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00614822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*